OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
August 01, 2011
Carrying the Weight of the Future
When it comes to the emerging markets, executing a few key elements of success are more important than ever.
Why does the match against medicines compliance always seem to end in an easy knockout?
A Q&A with Kristin Peck, the drugmaker's Executive Vice President, Worldwide Business Development and Innovation.
No one doubts the importance of health expenditures ? but then, euros, like dollars, don't grow on trees
Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed
It's a work in progres among EHR providers to offer a clear bridge between pharma and physicians.
From the Editor
What Big Pharma fails to see is how engagement in health policy is the biggest of reputation builders
A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation
When faced with legislative scrutiny, be prepared, be truthful, and don't be afraid to say 'I don't know'...
Having progressively improved its financial standings over the past decade, this Eastern European market is now a bastion of potential-to the tune of $1.2 billion
A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health
HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.
In medicines, as in life, the journey is just as important as the end result
Is Google+ the social media platform that pharma has been waiting for?